Safety and long-term efficacy of fractional CO₂ laser treatment in women suffering from genitourinary syndrome of menopause

Posted June 23, 2017

Behnia-Willison F., Sarraf S., Miller J., Mohamadi B., Care A.S., Lam A., Willison N., Behnia L., Salvatore S. Eur J Obstet Gynecol Reprod Biol. June 2017; 213:39-44. doi: 10.1016/j.ejogrb.2017.03.036. Epub 2017 Apr 2.

ad_mlt

Recent Posts

$Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms$ Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms
Fractional CO₂ laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.
Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO₂ Laser Treatment
Fractional CO₂ laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?